The sustained sub-75% combined ratio, driven by a loss ratio near 49% in Q2 2026, suggests superior risk selection and pricing discipline across all segments. The Q1 2025 spike to 85.2% appears to be an anomaly, likely reflecting catastrophe losses or reserve strengthening, but the subsequent recovery to the low-70s indicates the underwriting franchise remains resilient. Investors should monitor whether the low loss ratios are partly attributable to favorable prior-year reserve development, which may not persist.

The decomposition of ROE reveals that underwriting profits, not investment leverage, are the primary driver, with the underwriting margin averaging over 25% in the last four quarters. This is a hallmark of a high-quality insurer, as it indicates that Arch is generating returns from its core business rather than relying on financial engineering. The low debt-to-equity ratio of 0.11 further confirms that ROE is not inflated by leverage, making the earnings quality appear robust.

The wide fluctuation in the expense ratio, from single digits to mid-20s, appears to be a function of the business mix shift toward the primary insurance segment, particularly after the Allianz MidCorp acquisition. While the higher expense ratio may indicate lower operational efficiency compared to pure reinsurers, it is likely offset by a more stable and diversified earnings stream. Investors should compare Arch's expense ratio to that of primary insurers like WRB, rather than pure reinsurers, to gauge true efficiency.

The low debt-to-equity ratio, combined with a robust equity base of $24.0B, suggests that Arch has significant capacity to absorb underwriting shocks without breaching capital adequacy thresholds. The premium-to-surplus ratio, though not directly provided, is likely conservative given the company's disciplined approach to capital deployment. This financial flexibility may allow Arch to take advantage of hard market opportunities without overextending its balance sheet.

The significant P/B premium over pure-play reinsurers like RNR appears justified by Arch's superior ROE trajectory and the stabilizing influence of the mortgage segment. While RNR's P/B of 0.75 may indicate undervaluation, it also reflects the higher volatility and catastrophe exposure of a pure reinsurer. Arch's P/E of 8.55 is lower than Markel's 10.57, suggesting that despite the premium to RNR, it is not overvalued relative to other diversified insurers. The market appears to be pricing in the durability of Arch's underwriting margins and the counter-cyclical nature of its mortgage business.